Healthequity (HQY) Receives a Buy from Oppenheimer


Oppenheimer analyst Mohan Naidu maintained a Buy rating on Healthequity (HQY) today and set a price target of $98. The company’s shares closed yesterday at $82.87.

Naidu said:

“HQY wrapped up the year at the higher end of the pre-released FY19 numbers at revenue/adj. EPS of $287M/$1.19. Adj. EBITDA was also at the higher end at $118M. Growth in HSA members and AUM was well above the market and the yield for the quarter was at 2.30%. To continue to push for the market leading growth, management announced investments (~$30M) in five different areas to expand product, bolster security, drive broader HSA education and member engagement. Inclusion of HSA access to working Medicare-eligible individuals in the President’s budget is a welcome change after the lack of regulatory movement in HSA expansions as is optimism about making 10+ million members eligible for HSAs. Increasing our target to $98.”

According to TipRanks.com, Naidu is a 5-star analyst with an average return of 10.2% and a 55.0% success rate. Naidu covers the Services sector, focusing on stocks such as Tivity Health Inc, Hms Holdings Corp, and Evolent Health.

Currently, the analyst consensus on Healthequity is a Strong Buy with an average price target of $82.38, representing a -0.6% downside. In a report released yesterday, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $90 price target.

See today’s analyst top recommended stocks >>

Healthequity’s market cap is currently $5.17B and has a P/E ratio of 78.52. The company has a Price to Book ratio of 11.32.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthEquity, Inc. engages in the provision of healthcare saving solutions. Its products include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts